0.7785
price up icon3.99%   0.0299
pre-market  Pre-market:  .80   0.0215   +2.76%
loading

Spero Therapeutics Inc Stock (SPRO) Financials Data

Income Statement
Quarterly
*All numbers in millions
Period End Date 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Period Length 3 Months 3 Months 3 Months 3 Months 3 Months
Revenues
87.40%
9.267
73.52 25.47 2.716 2.069
Operating Expenses
1.13%
23.25
22.99 27.41 15.61 16.30
Benefits Costs and Expenses
72.01%
21.94
78.38 - 14.63 15.34
Costs And Expenses
15.05%
21.94
19.07 27.41 14.63 15.34
Operating Income/Loss
127.67%
-13.98
50.53 -1.934 -12.89 -14.23
Nonoperating Income/Loss
25.53%
1.313
1.046 0.94 0.976 0.961
Income/Loss From Continuing Operations Before Tax
160.95%
-12.67
-4.855 25.47 -11.91 -13.27
Income/Loss From Continuing Operations After Tax
124.75%
-12.67
51.19 -3.205 -11.91 -13.27
Net Income/Loss
124.75%
-12.67
51.19 -3.205 -11.91 -13.27
Preferred Stock Dividends And Other Adjustments
306.67%
-0.031
0.015 0.005 0.014 -0.034
Attributable To Noncontrolling Interest
306.67%
0.031
-0.015 -0.005 -0.014 0.034
Basic Average Shares
53,554%
53.52
0.0998 52.71 52.57 52.53
Diluted Average Shares
13,791%
53.52
0.3853 52.71 52.57 52.53
Basic Earnings Per Share
124.74%
-0.24
0.97 -0.06 -0.23 -0.25
Diluted Earnings Per Share
124.74%
-0.24
0.97 -0.06 -0.23 -0.25
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
306.67%
-0.031
0.015 0.005 0.014 -0.034
$75.07
price up icon 1.39%
$305.39
price down icon 0.55%
$19.19
price down icon 3.62%
$32.68
price down icon 0.52%
$97.47
price down icon 2.84%
biotechnology ONC
$254.57
price up icon 1.89%
Cap:     |  Volume (24h):